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Abstract
Bacteria communicate extensively with each other and employ a
communal approach to facilitate survival in hostile environments. A
hierarchy of cell-to-cell signaling pathways regulates bacterial
growth, metabolism, biofilm formation, virulence expression, and a
myriad of other essential functions in bacterial populations. The
notion that bacteria can signal each other and coordinate their
assault patterns against susceptible hosts is now well established.
These signaling networks represent a previously unrecognized
survival strategy by which bacterial pathogens evade antimicrobial
defenses and overwhelm the host. These quorum sensing
communication signals can transgress species barriers and even
kingdom barriers. Quorum sensing molecules can regulate human
transcriptional programs to the advantage of the pathogen. Human
stress hormones and cytokines can be detected by bacterial
quorum sensing systems. By this mechanism, the pathogen can
detect the physiologically stressed host, providing an opportunity
to invade when the patient is most vulnerable. These rather sophis-
ticated, microbial communication systems may prove to be a
liability to pathogens as they make convenient targets for thera-
peutic intervention in our continuing struggle to control microbial
pathogens.
Introduction
When first encountering a new host, every potential microbial
pathogen is presented with three possible options. The
microorganism can stay and play (colonize and establish
biofilms), or can scoop and run (transiently colonize, acquire
nutrients, and then seek another host). Alternatively, the
pathogen could throw caution to the wind, express its full
complement of virulence factors, and invade the host. It may
come as a surprise to learn that this decision is often not
made in isolation. The notion that a bacterium survives
essentially as a lone soldier whose success or failure is
dependent upon mere happenstance alone has given way to
a more complex and nuanced view of microbial pathogenesis.
Successful invasion of a host is now understood to be a
collective process, predicated upon microbial information
sharing and active collaboration [1,2].
Pathogens employ a series of chemical signals and sensing
systems that jointly engage bacterial communities to
genetically respond in concert to specific conditions existing
in their immediate microenvironment. An emerging field
termed sociomicrobiology is beginning to unravel the evolu-
tionary, ecologic, and functional advantages of communal
living among bacterial populations. A central component of
bacterial communication is known as quorum sensing (QS).
QS is defined as the capacity to detect extracellular, small-
molecule signals and to alter gene expression in response to
bacterial population densities. Elements of the QS apparatus
of bacteria are now known to serve a wide variety of functions
beyond a simple estimate of cell density [3,4]. Bacteria use
QS signals to coordinate gene expression within their own
kind. Moreover, these same sensing signals are used to either
inhibit or activate transcriptional programs among competing
bacterial strains and other species existing within the same
microenvironment [5]. Communication can even cross
kingdom boundaries, as bacterial QS effector molecules can
alter transcriptional programs found in eukaryotic epithelial
cells and immune effector cells [4,6].
Potential microbial pathogens face very long odds when
attempting to successfully invade a human host. An impres-
sive repertoire of antibacterial defenses awaits any micro-
organism that transgresses the human epithelial barrier [7-9].
In response, a myriad of rather ingenious defensive and
offensive weaponry is expressed by microbial invaders. A
pathogen must evade host innate and acquired cellular and
humoral immune responses, replicate at a sufficient rate to
overwhelm host clearance mechanisms, and cause tissue
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injury. In the present brief review we shall discuss the mecha-
nisms by which bacteria communicate, and discuss how this
capability is exploited by pathogens to successfully invade
the host.
The discovery of QS is attributable to the pioneering work of
three marine microbiologists – Nealson, Platt and Hastings
[10]. An unusual form of symbiosis exists between the halo-
philic bacterium Vibrio fischeri and Hawaiian bobtail squid
(Euprymna scolopes). The bioluminescent V. fischeri is taken
up by strategically placed light organs along the outer surface
of the squid. When the bacterial population reaches a
threshold concentration, the bacterium activates its luciferase
operon to generate visible light. The bacteria benefit from its
association with the squid, which provides a safe haven and a
steady source of nutrients. The light source created by the
bacterial enzymes provides the squid with an ingenious form
of camouflage. The dark outline of the squid is silhouetted
against the starlit sky on clear nights, rendering them readily
visible from below by predatory fish [11]. The light organs of
the squid provide a starry sky camouflage thanks to the light
source provided by the large aggregates of V. fischeri.
Bioluminescence by this Vibrio species, and a closely related
organism Vibrio harveyi, is activated only when large concen-
trations of bacteria are present. But how do individual bac-
terial cells sense when their population density is sufficient to
generate bioluminescence? The answer came when
V. fischeri was found to produce a soluble QS molecule that
only induces transcription of the luciferase operon when
neighboring bacterial populations are above a preset
threshold concentration [4,11,12].
Quorum sensing systems in microbial
pathogens
The practical relevance of these initial, astute observations in
V. fischeri was largely overlooked by clinical microbiologists,
whose primary interest revolves around the study of human
pathogens. Biologists certainly appreciated QS as a
remarkable adaptation and prime example of mutualism in the
field of marine ecology, but this work did not attract much
attention until researchers began to find homologous, auto-
inducer systems among many clinically relevant, microbial
pathogens [1-6,11-14].
Many common bacterial pathogens, including Escherichia
coli, Pseudomonas aeruginosa, Bacteroides, Yersinia, Burk-
holderia and Enterococcus spp., and many clinically impor-
tant staphylococcal and streptococcal pathogens contain QS
genes. Cell-to-cell communication via QS systems might
contribute to the global regulation of multiple bacterial genes,
including virulence genes, under specific environmental and
growth conditions. Up to 15% of the open reading frames of
bacteria are controlled by QS molecules [4]. QS can
promote the growth of related strains of bacteria (referred to
as alloinduction) and can simultaneously inhibit the growth of
other bacterial [15], or even fungal, organisms competing for
the same ecologic niche [6,16].
QS gene products regulate a multitude of transcriptional
programs in bacteria in vitro and probably in vivo. QS systems
control biofilm formation [17-27], growth potential, sporulation,
antibiotic resistance expression, DNA transfer, virulence
expression, autolysis, oxidative stress tolerance, metabolic
activity, motility, antibiotic synthesis by antibiotic-producing
bacteria, sessile versus planktonic behavior, and – most
importantly – genetic determinants of virulence [1-3,11-14].
Bacterial pathogens possess an array of genes on patho-
genicity islands scattered around their chromosome,
plasmids and lysogenic bacteriophages, which function
together to mediate microbial virulence [28,29]. This total
complement of virulence genes is now referred to as the
virulome [30]. How global regulation of the virulome is
accomplished by QS mechanisms will be the primary focus of
the present review.
Quorum sensing signal molecules and sensor
systems
A remarkable array of signaling molecules can function as
local sensors to communicate population densities in Gram-
negative and Gram-positive bacteria. These molecular signals
and their receptors are broadly grouped into three, and
possibly four, QS systems. The general features of each type
of the QS systems identified thus far are presented in Table 1.
Autoinducer type 1 system
The autoinducer type 1 system is widely used in multiple
genera of Gram-negative bacteria and is highly homologous
to the original luxR/luxI autoinducer type 1 system in Vibrio
spp. first defined in V. fischeri [8]. A highly soluble and freely
diffusible sensor molecule uses a series of N-acyl homoserine
lactone (AHL) molecules for signaling (Figure 1).
AHL molecules vary in the N-acyl chain length (from 4 to 18
carbons), the degree of saturation, and the number of oxygen
substitutions. The L-isomeric form of the homoserine lactone
ring is common to all AHLs. The luxI gene, or its homologues,
encodes the sequences that mediate the formation of the AHL
signaling molecule. AHLs freely pass though cell membranes
and, when bacterial population densities are low, limited
amounts of the AHL are diluted away and the genes under QS
control remain turned off. When population densities increase
beyond a predetermined threshold level, enough AHL
accumulates to interact with its cytosolic receptor.
The receptor for AHL is mediated by the luxR gene in
V. fischeri or related genes in other bacterial species. The
translated product of luxR is the LuxR receptor molecule,
which together with its AHL partner functions as a coactivator
complex at the promoter sites for QS responsive operons in
bacterial genome. In V. fischeri the end result is biolumines-Page 3 of 11
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cence; for certain bacterial pathogens, the end product is the
activation of the virulome for microbial invasion.
The autoinducer type 1 system is found in many medically
important, Gram-negative bacterial pathogens [1-5,31]. Some
the bacterial genera use the same AHL molecule, indicating
some level of interspecies cross-talk probably exists [4].
Other bacteria including E. coli do not synthesize AHLs but
express a LuxR biosensor homologue (SdiA). It is speculated
that this sensing system allows E. coli to listen in on com-
munication signals from other Gram-negative bacteria and
exploit this information to its own advantage [32].
There are many variations on this central theme among the
QS apparatus of specific bacterial pathogens. P. aeruginosa,
for example, actually deploys at least two such AHL signaling
systems simultaneously (the autoinducer type 1 system in
P. aeruginosa, the lasR/lasI (3-oxo-C12-homoserine lactone)
system; and the autoinducer type 1 system in P. aeruginosa,
the  rhlR/rhlI (C4-homoserine lactone) system) to jointly
regulate biofilm synthesis and virulence [31].
LuxS autoinducer type 2 signaling system
A second QS pathway was initially discovered in the
V. harveyi bioluminescence system and is mediated by the
luxS gene locus and related homologues [1,5]. Elements of
the autoinducer type 2 (AI-2) system are detectable in almost
one-half of all sequenced bacterial genomes, and this system
is now recognized as the most ubiquitous signaling system
employed by both Gram-negative and Gram-positive bacteria
[3,9,33]. The AI-2 pathway uses a more complex, two-
component, receptor-kinase network to accomplish efficient
signaling among bacteria (see Figure 2). Structurally, the AI-2
signal in Vibrio spp. is composed of rather complex, multiple-
ringed, cyclical furanosyl molecules containing the highly
unusual presence of a boron atom [5].
The receptor for the AI-2 apparatus is also complex, with a
series of gene products that function as the receptor-kinase
signal transcription complex. In Vibrio species the receptor is
a membrane-bound, two-domain, sensor kinase and response
regulator (LuxQ). In enteric bacteria, a soluble receptor binds
Available online http://ccforum.com/content/12/6/236
Table 1
Basic elements of the quorum sensing systems in bacteria
Type Sensing molecules Receptor(s) Special features
Autoinducer type 1, LuxR-I type N-acyl-homoserine lactones Intracellular Lux-R homologues  Found in Gram-negative bacteria 
as transcriptional coactivator (Burkholderia, Vibrio, Pseudomonas 
spp.); might affect human genes
Autoinducer type 2, LuxS type Heterocyclic furanosyl-borate Two-component membrane  Widespread in Gram-negative and 
receptor-cytoplasmic kinase  Gram-positive bacteria; might be a 
complex primary metabolic system rather than a 
communication system
Autoinducer type 3,  Catecholamine-like molecules Two-component membrane- Found in Gram-negative, enteric 
epinephrine/norepinephrine sensor  kinase/response  bacteria  enterohemorrhagic  Escherichia 
signaling system regulator (QseBC) coli, enteropathogenic E. coli, Shigella,
Salmonella spp.; functional role unclear 
at present
Cyclic short-peptide systems  Small cyclic peptides with  Two-component sensor kinase  Gram-positive bacteria, 
(AgrC/AgrA, staphylococci;  thiolactone ring (AgrC)-response regulator  Staphylococcus, Bacillus,
competence stimulating  (AgrA) Enterococcus, Streptococcus spp.
peptide, pneumococci; 
Enterococcus faecalis regulator, 
enterococci)
Agr, accessory gene regulator; QseBC, autoinducer type 3 system in enteric bacteria.
Figure 1
Autoinducer type 1 quorum sensing signal system in Gram-negative
bacteria. The autoinducer type 1 quorum sensing (QS) system found in
Vibrio fischeri, and many homologous variations on the system in other
Gram-negative bacteria. AHL, acyl homoserine lactone; luxR/luxI,
autoinducer type 1 system in Vibrio spp.; P, promoter site.to the AI-2 signal molecule in the periplasmic space and then
transports the AI-2 molecule across the membrane via a
specific ABC-type transporter system [17]. The internalized
AI-2 molecule is phosphorylated and then complexes with an
intracellular receptor that acts as the transcriptional activator.
Multiple variations of this AI-2 system are found in bacteria
[6]. The AI-2 signaling molecule in Salmonella spp. is a furane
molecule that lacks boron. Many bacteria apparently do not
express the luxS gene but do express the AI-2 receptor
complex [17,19]. Such an arrangement has been proposed
to allow some bacterial strains to sense and use AI-2 signals
generated by other bacteria to regulate their own coordinated
transcriptional responses [6,19]. While this is an intriguing
hypothesis, there is as yet no convincing, direct evidence that
AI-2 signals from one species can regulate the gene expres-
sion of an unrelated species.
The precise role of AI-2 signaling in bacterial pathogenesis is
not clear, as much of the transcriptional activity of AI-2
systems is directed toward regulation of metabolic pathways
[3,17]. In addition to its potential role as an AI-2 synthase, the
luxS gene encodes a dual-function enzyme that mediates the
conversion of the toxic intermediate molecule S-adenosyl-L-
homocysteine to homocysteine. This enzymatic activity is
central to an activated methyl cycle in which methyl groups
are attached to nucleic acid precursors, proteins and other
metabolites. Byproducts of LuxS enzyme activity are furanose
structures that act as AI-2 signals [34,35].
Many of the QS signaling events ascribed to AI-2 signaling
may, in fact, be the consequence of LuxS as a detoxifying
enzyme in the activated methyl cycle rather than a consequence
of QS effects. Recent, direct genetic evidence in luxS
mutants of Streptococcus mutans indicates that many but not
all of the phenotypic effects of AI-2 can be ascribed to the
metabolic impact of LuxS rather than its QS effects [36]. A
total of 585 genes (30% of the transcriptome) were altered
by deletion of luxS; however, only 59 gene transcripts were
upregulated by addition of AI-2. These data assign a primary
metabolic role of LuxS, with a potential secondary role in QS
signaling [36]. As seen in some examples provided in the
following section, however, AI-2 signaling might play a
facilitating role in bacterial virulence with some pathogens
[19,37,38].
Autoinducer type 3 system
This newly discovered QS system is perhaps the most
complicated of all signaling pathways thus far discovered.
The autoinducer type 3 (AI-3) system shares many charac-
teristics of the AI-2 system as it uses a two-component,
receptor kinase-intracellular signaling complex to activate
genes of the virulome; but, in contrast to AI-2, the AI-3 system
can use the human stress hormones epinephrine or nor-
epinephrine to signal the system (see Figure 3) [11,39-41].
The natural microbial ligand molecule that activates the AI-3
receptor complex has not been clearly defined but is probably
similar to catecholamines. In fact, α-adrenergic receptor
blocking agents can block AI-3 signaling in E. coli [17].
The periplasmic receptor for the AI-3 system has recently
been characterized and is known as the QseBC complex
[42]. QseC is the sensor kinase and QseB is the phosphory-
lated response regulator that alters transcription of virulence
genes. The AI-3 system is essential in the pathogenesis of
enterohemorrhagic  E. coli infections and shigellosis [17].
Components of the AI-3 signaling network have been
detected in enteropathogenic E. coli strains, commensal
E. coli strains, and a number of other Gram-negative, enteric
organisms, but thus far not in Gram-positive bacteria.
Short peptide signaling system in Gram-positive bacteria
Some Gram-positive bacterial pathogens also possess another
structurally dissimilar, but functionally similar, system of global
regulation of genes based upon cell densities [20,43]. This
system is referred to as the accessory gene regulator system
(agr) in staphylococci [43] and as the Enterococcus faecalis
regulator-QS (frs) system in enterococci [44]. Gram-positive
pathogens rely upon short, cyclical peptides known as auto-
inducer peptides (AIPs). The AIPs of Staphylococcus aureus
usually feature cyclical short peptides from seven to nine
amino acids in size with terminal thiolactone ring structures.
The ring formation is created by linkage of the carboxyl
terminus with a conserved cysteine moiety within the peptide
sequences.
Cell surface receptors sense these peptides and activate a
histidine kinase that generates transcriptional activators for
multiple gene loci. The agr genetic locus is best character-
ized in S. aureus (see Figure 4) and consists of two operons
denoted as RNAII and RNAIII. RNAII contains four open
Critical Care    Vol 12 No 6 Asad and Opal
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Figure 2
Two types of autoinducer type 2 quorum sensing systems in different
genera of Gram-negative bacteria. The two autoinducer type 2 (AI-2)
quorum sensing signal systems found in Salmonella spp. and in Vibrio
spp. ABC, ATP-binding cassette transporter; Lrs, LuxS regulated; P,
promoter site; P*, phosphorylated; Vir, virulence.reading frames designated agrA to agrD [20,30]. The current
working model suggests that the autoinducer peptide is
generated from agrD and then processed, post-translationally
modified, and secreted by a membrane-bound protein
bearing an ABC-type transporter system known as AgrB. The
sensing apparatus consists of the transmembrane receptor-
histidine kinase AgrC. If sufficient quantities of the appro-
priate AIP ligand have accumulated, AgrC phosphorylates
AgrA. Then AgrA acts as a transcriptional activator with
binding to the promoter sites of both RNAII and RNAIII [30].
RNAII activation functions as a positive feedback loop for
more AIP synthesis. There are four recognized agr groups in
S. aureus. The same AIP peptide that autoactivates the producer
strain of S. aureus will inhibit signaling with other peptide
groups of the same species [20,45]. These cross-inhibitory
effects of autoinducing peptides are envisioned as a mecha-
nism to reduce competition by multiple strains of S. aureus
within confined ecologic niches with limited resources [3].
RNAIII is the effector gene with dual roles in virulence
expression. The transcribed product of RNAIII mediates delta-
toxin synthesis and also functions as a regulatory RNA
sequence that alters the expression of multiple other genes of
the virulome [20]. Activation of the agr system by high con-
centrations of AIP with some peptide groups of staphylococci
will generate RNAIII, which upregulates the expression of a
large number of pathogenic exotoxins. These endotoxins
include toxic shock syndrome toxin-1, delta toxin, exfoliatin,
hemolysins, some but not all the staphylococcal super-
antigenic enterotoxins, and the Panton-Valentine leukocidin
[20]. RNAIII synthesis simultaneously downregulates a
number of surface proteins, clumping factor, and adhesion
molecules. The intricate role of the agr system in gene
regulation and virulence will be discussed in greater detail
later (see section Quorum sensing systems in the patho-
genesis of S. aureus infections) [2,3,20].
Quorum sensing, biofilms, and bacterial
communal living
QS is thought to play a role in the production of healthy and
fully developed biofilms. These complex, microbially derived,
multilayer structures of defined architecture form relatively
stable bacterial communities living in a sessile, protected
environment [2,11,46-49]. The widespread presence of
biofilms on foreign bodies (for example, prosthetic device
infections, prolonged use of urinary and vascular catheters) or
host surfaces (endovascular and epithelial surfaces) attest to
the survival advantages afforded by bacterial biofilms [46,50].
The slow rate of metabolism and their physical location within
biofilm exocapsular structures protect bacteria against the
bactericidal effect of antibiotics and host clearance
mechanisms by opsonins and neutrophils [27]. The clinical
consequences of infection associated with mature biofilms
are significant. Prolonged antibiotic therapy is often required
to eradicate these infections (that is, osteomyelitis, endo-
carditis, catheter-related infections); regrettably, even this
strategy often fails – necessitating surgical excision of the
biofilm-contaminated source for long-term cure [1,18,49,51].
The formation of biofilms is a multistep process beginning
with microbial surface attachment, cell-to-cell aggregation
and proliferation, exopolysaccharide matrix production, growth,
maturation, and, finally, biofilm detachment or degradation
Available online http://ccforum.com/content/12/6/236
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Figure 3
Autoinducer type 3/epinephrine quorum sensing system in enteric
Gram-negative bacteria. AI-3, autoinducer type 3; EHEC,
enterohemorrhagic Escherichia coli; LEE, locus for enterocyte
effacement; flh, flagella regulon; P, promoter site; P*, phosphorylated;
Qse, AI-3 system in enteric bacteria.
Figure 4
Accessory gene regulator quorum sensing system in Staphylococcus
aureus. Homologous short peptide signaling systems exist in other
Gram-positive bacterial species and genera. agr, accessory gene
regulator; AIP, autoinducer peptide; P, promoter site; P*,
phosphorylated protein; RAP, RNAIII-activating protein; RIP, RNAIII-
inhibiting peptide; TRAP, target of RNAIII-activating protein.[3,20,48,49]. QS systems appear to be involved in all phases
of biofilm formation. They regulate the population density and
the metabolic activity within the mature biofilm to fit the
nutritional demands and resources available. Bacteria resid-
ing within biofilms have markedly different transcriptional
programs from free-living planktonic bacteria of the same
strain. Recent evidence in Streptococcus pneumoniae indi-
cates that organisms existing in a sessile state from biofilms
are better able to establish localized infections in lung tissue
than isogenic organisms in a planktonic physiologic state
[46]. The reverse was found in experimental models of primary
bacteremia. The planktonic, free-living organisms were
significantly more virulent in bacteremic infection than the
same organism grown from biofilms [46].
QS networks also appear to be instrumental in the release of
bacteria from the extracellular matrix of the biofilm. The
protected sanctuary provided by biofilms presents a problem of
escape from the extracellular matrix in which the bacteria
reside. When population densities in biofilms become high,
some evidence suggests that staphylococci might use AI-2
signals to reduce the production of polysaccharide intercellular
adhesin to permit bacteria to escape the biofilm [20,30]. Short
peptides with detergent qualities that are under QS control are
also deployed to release bacteria for biofilms when cell
densities are high. Sessile bacteria in biofilms provide a
continuous source of planktonic bacteria as bacterial
populations expand. This is clearly evidenced by the continued
release of bacteria into the bloodstream in patients with
endocarditis from endovascular biofilms within vegetation [49].
Biofilm-like communal living may even extend to microbial
populations residing within the intracellular space. Intra-
cellular bacterial communities have been identified in
epithelial cells in some patients with seemingly uncompli-
cated urinary tract infections. Rosen and colleagues recently
reported detection of intracellular bacterial communities in
18% of young, sexually active women with E. coli cystitis
[52]. Up to 41% of urine specimens in women with cystitis
have evidence of filamentous bacterial forms, a hallmark of
sessile bacterial communities. Cytologic evidence of intra-
cellular bacterial communities within exfoliated urinary
epithelial cells is readily demonstrable in women with acute
cystitis. Apparently some uropathogenic E. coli have evolved
the capacity to invade epithelial lining cells where they reside
in quasi-stable intracellular communities, avoiding immune
surveillance and urinary clearance mechanisms [52,53].
Examples of quorum sensing systems as
contributors to microbial pathogenesis
among some common human pathogens
Quorum sensing systems in P. aeruginosa
P. aeruginosa has a remarkably diverse metabolic capacity to
exist in multiple environments and possesses an unusually
large chromosome. This extensive array of genetic material is
tightly regulated, and P. aeruginosa uses QS as one of its
global regulators of the virulome and its complement of
metabolic enzymes [18,19,54].
Pseudomonas spp. produce at least two distinct AHL signal
molecules from the lasR-I and  rhlR-I loci, which are hier-
archically controlled and work in concert to control virulence
and biofilm formation. The lasI  product is 3-oxo-C12-
homoserine lactone, and the rhlI product is a shorter C4-
homoserine lactone. The lasR-I signals are the primary deter-
minant of virulence and biofilm formation, and regulate the rhl
system [31]. A third LuxR homolog (QscR) is known to exist
in P. aeruginosa that regulates the expression of both the lasI
and rhlI QS gene loci [3]. P. aeruginosa also possesses a
separate signaling system known as the Pseudomonas
quinolone signal that generates a 4-quinolone signaling
molecule 2-heptyl-3-hydroxy-4-quinolone [54]. This signaling
system is interposed between the las and rhl QS signaling
systems. The lasR-I system induces this Pseudomonas
quinolone signal, and the Pseudomonas quinolone signal
induces the RhlR-I QS system. Pseudomonas quinolone
signal is expressed in infection and induces the synthesis of
several important virulence factors, including pyocanin,
rhamnolipid, lectins, and elastase [54].
These QS systems provide an opportunity for pathogens to
minimize early losses and maximize the chances for ultimate
success in causing widespread infection and sepsis. The
virulome is repressed when population densities are low. This
prevents early detection and avoids immune activation
against these immunostimulatory virulence factors in the initial
phase of colonization of the host. Once the population
density expands to critical threshold levels, QS systems
activate replication programs and the full expression of virulence
programs. Virulence factors include proteases (elastase,
alkaline protease), antibiotic resistance, motility, sidero-
phores, adhesins, phospholipases, cytotoxins and other exo-
toxins, along with type III secretion systems and inducers of
neutrophil and macrophage apoptosis [5,16,18,55-57].
Additionally, P. aeruginosa expresses the receptor complex
of the AI-2 two-component signaling system, but it does not
contain the gene of a luxS signaling pathway or generate any
of its own AI-2 signal molecules. P. aeruginosa possibly uses
this system to detect AI-2 signals from other competing or
commensal bacterial populations within its immediate micro-
environment [19].
Site-specific, QS gene deletion experiments have been
undertaken in an effort to decipher the role of QS in vivo in
virulence and biofilm formation. P. aeruginosa strains with
genetically defined, excision mutations of the QS gene
complex exhibit significantly impaired virulence in animal
models of invasive infections (for example, burns, pneumonia,
and bacteremia) [31,50,58,59]. Biofilms generated from these
lasR-I mutants display a disordered and blunted architecture
[18]. Full virulence and normal biofilms are restored by comple-
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replace the genes for the lasR-I QS into the pathogen [50].
AHLs produced by P. aeruginosa may have a further survival
advantage by eliminating some of its microbial competitors.
The AHL produced by lasI inhibits the virulence, growth, and
survival potential of some strains of S. aureus. This activity is
mediated by the inhibition of the agr and  sarC regulatory
gene circuitry of the S. aureus QS system [15].
The capacity to recognize AI-2 signals is probably advan-
tageous for Pseudomonas spp. in assessing the population
density of competing bacteria on mucosal surfaces. A
previously unappreciated, direct, synergistic interaction exists
between  P. aeruginosa virulence expression and other
colonizing bacteria of the oropharynx using cross-species
AI-2 signaling. Oropharyngeal bacterial flora release AI-2
signals in the respiratory tract and may be sensed by
P. aeruginosa in microbial communities such as those found
in the airways in cystic fibrosis or in diffuse panbronchiolitis
[19,55]. Seemingly innocuous oropharyngeal flora may
enhance P. aeruginosa-induced lung injury in animal models
by releasing AI-2 signals that upregulate P. aeruginosa
virulence genes. Substantial quantities of AI-2 can be
measured in the respiratory secretions in cystic fibrosis
patients, suggesting that this may of clinical significance in
some patients with P. aeruginosa pneumonia [19].
Quorum sensing systems in E. coli pathogenesis
Biofilm communal living is a common characteristic among
E. coli infections along catheter surfaces and on mucous
membranes along epithelial surfaces [1,26,49]. Bacterial
communities residing on urinary catheter surfaces are
relatively refractory to the lytic action of many antibiotics. The
intracellular bacterial communities with E. coli residing within
uroepithelial cells also shelter bacteria from many anti-
microbial agents that are limited to the extracellular space
[52]. The QS systems expressed by E. coli are instrumental
to biofilm construction. Moreover, a number of QS networks
regulate the synthesis of an array of E. coli virulence factors in
enteric infections and extra-intestinal infections [41].
No E. coli gene for luxI-type autoinducer type 1 homoserine
lactones has been described thus far, but a gene homologue
for the LuxR receptor, known as sidA, is expressed in some
stains of E. coli. This receptor could recognize AHL molecules
produced by other bacterial genera, providing E. coli with a
mechanism to detect competing bacterial populations [17].
Components of the AI-2 and AI-3 QS systems are found in
E. coli strains and might play a role in microbial pathogenesis.
The AI-2 system was initially thought to regulate the E. coli
virulome, but current evidence ascribes a primary metabolic
control function for AI-2 systems [17,35]. The epinephrine/
norepinephrine AI-3 system regulates many virulence genes
in E. coli strains, including the attaching and effacing colonic
lesions essential to the pathogenesis of enterohemorrhagic
E. coli infections [40,60]. Deletion of the AI-3 receptor
attenuates enterohemorrhagic E. coli infection in animal
models. This QS network might also regulate motility and
promote adhesion expression for biofilm formation in the early
phases of enteropathogenic E. coli infections [17].
Quorum sensing systems in the pathogenesis
of S. aureus infections
QS-mediated virulence gene regulation is fine tuned in some
strains of S. aureus, where the specific sets of virulence gene
transcriptional programs are phased on or phased off in
preset patterns over the course of an invasive infection [20].
S. aureus has at least two QS systems at its disposal plus a
large number of other sensing systems and transcriptional
and post-transcriptional control mechanisms. The cyclic
peptide Agr system is the dominant QS regulator of genetic
programs in S. aureus. This major human pathogen, and
other staphylococcal species, might also, however, use LuxS
signals to regulate virulence and to initiate detachment from
biofilms by expression of phenol-soluble modulin peptides
[25,38].
In the early phase of microbial invasion, the population
density is low and most virulence genes are turned off in favor
of surface adherence structures and the immunoglobulin
inhibitory molecule, protein A. This is controlled by low agr
expression and the sarA regulon of S. aureus. Once infection
begins in earnest, the QS apparatus is activated and
sequential gene activation rapidly proceeds with exotoxin,
protease, and hemolysin production [20]. Simultaneously,
adhesin molecule expression is turned off, thereby facilitating
dissemination to other regions in the host. In vivo detection of
agr expression indicates that a biphasic activation of the
system occurs with early activation, secondary reduction, and
then late reactivation of this QS system during infection [61].
Deletion mutations of the agr system in S. aureus
experimental infection models generally, but not uniformly,
support a functional role for this QS system in invasive
staphylococcal disease [20,30].
Biofilm formation is actually inhibited by both the agr system
and AI-2 signals in staphylococci. The utility of QS in
staphylococcal biofilms may actually be the expression of
solublizing enzymes and phenol-soluble modulin peptides
that permit release and detachment of bacteria from mature
biofilms [30,38]. This detachment process appears to be
under QS control and facilitates dissemination of S. aureus to
distant sites with establishment of metastatic foci of abscess
formation. This process is characteristic of infection by this
highly virulent, Gram-positive pathogen.
Interspecies and interkingdom signaling via
quorum sensing systems
QS biosensors might provide other advantages for bacterial
pathogens as environmental cues to the presence of nearly
Available online http://ccforum.com/content/12/6/236
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communication signals from other bacteria may simply
indicate undirected background chatter, or they might
provide some form of general alert signal [12]. Bacteria might
actually consume AI-2 signals produced by neighboring
species and disrupt their QS-regulated gene activation [62].
Bacteria appear to be capable of usurping the signaling
potential of some bacterial strains to their advantage, without
expending the metabolic energy necessary to generate their
own communication system. This form of eavesdropping or
cheating may be quite common in complex bacterial
communities [63,64].
Some QS signal molecules may have more direct survival
value for the producer strains. The staphylococcal Agr system
can inhibit the growth of the eukaryotic fungal pathogen
Candida albicans [4]. This is a clear survival advantage for
these bacterial strains competing with fungi for limited space
within a common ecologic niche (that is, the respiratory
mucosal surface in a mechanically ventilated patient). Elimina-
ting microbial competition permits QS-bearing bacteria
unfettered access to nutrients and favored staging areas
within the host for microbial invasion [1].
More complex pathways of communication exist, including
two-way signaling between human cells and QS among
bacterial populations. That such a system exists is evidenced
by recent experiments that identify QS-dependent alterations
of multiple genetic programs, epithelial cells, and immune
effector cells in patients [6]. AHL molecules freely diffuse
into human cells and bind to intracellular signaling proteins.
These proteins transcriptionally regulate human genes that
mediate the host response to bacterial invasion such as
chemokines and cytokines. AHL molecules of Gram-negative
bacteria promote a shift from a T-helper type 1 cytokine
response to a T-helper type 2 cytokine response, an environ-
ment more hospitable to bacterial growth [3]. The micro-
organism gains a distinct advantage in host:pathogen inter-
actions if the human immune response can be regulated by
the pathogen. QS molecules promote apoptosis of human
neutrophils [56,65], stimulate mucin production in the airway
epithelium [24,66], and can even promote vasodilatation in
the microcirculation [67].
Interkingdom communication via bacterial QS networks can
be bidirectional. Not only can bacteria signal human cells, but
human cytokines can also signal bacteria using QS circuitry.
Alverdy and colleagues uncovered the capacity of human
stress molecules to be recognized by the QS systems of P.
aeruginosa [68]. A specific receptor for human IFNγ exists on
the outer membrane (OmpF) of some P. aeruginosa strains
that can activate QS-regulated virulence genes. Excess levels
of IFNγ signify a compromised and possibly vulnerable host.
Activation of virulence genes and invasive phenotypes during
times of host stress favors the infecting microorganism
against a weakened host.
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Table 2
Selected quorum sensing inhibitors as potential therapeutic agents
Agent References Target Proposed mechanism of action Current status
Macrolide and  [24,66,71] AHL signal generation Inhibit C12-homoserine lactone by  Experimental use of 
aminoglycoside  Pseudomonas aeruginosa quorum existing  antibiotics
antibiotics sensing system 
S-adenosyl-homosysteine [70] AHL signal generation Inhibits generation of AHL by RhlI  In vitro testing
synthesis
Antibody to AHL [80] C12-homoserine lactone  Antibodies to AHL block cell to cell  In vitro and animal 
of P. aeruginosa signaling models
AiiA degrading enzymes [70] AHL lactone ring Lactonolysis of AHL disrupts signaling  In vitro testing; might be 
potential useful as topical agent
PvdQ-type degrading  [70] Fatty acid side chain of  Aminoacylase releases fatty acid and  In vitro studies
enzymes AHL destabilizes lactone ring 
Halogenated furanones,  [70,72,73,75] AHL receptors and LuxR  Competitive inhibitors for AHL  In vitro and animal 
other natural or synthetic  homologues receptor binding studies
AHL analogues
RIP and similar RNAIII- [47,76,78,79] TRAP in agr peptide  Inhibits phosphorylation of TRAP  In vitro and animal 
inhibiting peptides system  blocking RNAIII signaling studies
RAP inhibitors [77] RNAIII-activating protein  Bind RAP and block agr activation  In vitro and animal 
of staphylococci  studies
agr, accessory gene regulator; AHL, N-acyl homoserine lactone; RAP, RNAIII-activating protein; RIP, RNAIII-inhibiting peptide; TRAP, target of
RNAIII-activating protein.Quorum sensing systems as a new treatment
strategy against bacterial pathogens
Inhibitors of these cell-to-cell bacterial communication
systems may provide a much needed novel treatment
modality against bacterial infections. Progressive emergence
of resistance to standard antibiotics in many bacterial patho-
gens threatens the very future of the modern antimicrobial era
[69]. New drugs that interfere with microbial virulence and
biofilm formation would be a welcome addition to our
therapeutic armamentarium against bacterial pathogens [62].
As QS is not essential to bacterial growth or viability, selection
pressures to resist QS inhibitors should, at least theoretically,
not be as major an impediment to QS inhibition drug
development as it is with antibiotics [70]. Some standard
antibiotics may have unintended benefits in the management
of bacterial infections independent of any intrinsic bactericidal
properties. As an example, the macrolide antibiotics can block
C12-homoserine lactone production by P. aeruginosa [24,66,
71]. This AHL promotes mucous production in patients with
pulmonary infections [24]. Despite the lack of intrinsic activity
of macrolides against this pathogen, limitation of excess mucin
production may aid in the resolution of persistent airways
infection with P. aeruginosa [71].
Natural and synthetic molecular mimics of autoinducer type 1
and AI-2 signaling structures are under study as inhibitors of
QS [72-76]. A short peptide known as RNAIII-inhibiting
peptide inhibits the initiation of agr-mediated biofilm formation
by staphylococci in experimental studies of vascular graft
infection [47,77]. This peptide and similar QS inhibitory
strategies have been proposed as locally applied or
systemically administered agents to prevent vascular graft
infections [77-79]. It may even be possible to vaccinate
susceptible hosts against P. aeruginosa autoinducer type 1
signal molecules and generate protective antibodies to
disrupt QS [80].
The current status of these QS inhibitors as potential
therapeutic agents is summarized in Table 2. A number of
these agents appear promising in vitro and in animal models
but, other than the experimental use of existing macrolide
antibiotics as QS inhibitors, none have reached clinical trials
in patients. Human trials have been delayed until toxicity, drug
penetration, potency, and feasibility issues with QS inhibitors
are resolved. Hopefully, some of these antibodies and small-
molecule inhibitors will ultimately provide new treatment
options in the clinical management of bacterial infections.
Summary and conclusions
QS systems serve many functions for bacterial pathogens.
QS provides a system to coordinate the expression of
virulence based upon cell densities by many common and
medically important bacteria. The molecular details of these
signaling networks are now being defined in both Gram-
positive and Gram-negative bacterial pathogens. Cross-talk
via conserved QS signals between different bacterial species
and even between prokaryotes and eukaryotes (including
humans) appears feasible and may be commonplace.
Understanding these signaling pathways might provide new
treatment options to disarm potential pathogens and improve
the outcome in septic patients.
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